Invesco Ltd. Capricor Therapeutics, Inc. Transaction History
Invesco Ltd.
- $516 Billion
- Q4 2024
A detailed history of Invesco Ltd. transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 14,678 shares of CAPR stock, worth $168,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,678
Previous 12,178
20.53%
Holding current value
$168,797
Previous $185,000
9.73%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CAPR
# of Institutions
132Shares Held
15.9MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$26.2 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$25.9 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$25.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$18.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$10.1 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $280M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...